SEC Form 4 · accession 0001572426-16-000203
Nexvet Biopharma plc · NVET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
John Bernard Payne
Director
Period of report
Jul 1, 2016
Accepted (ET)
Jul 1, 2016 · 9:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jul 1, 2016 | M | 3,600 | $0.125 | A | 3,600 | D | |
| Ordinary SharesF1 | holding | — | — | — | 6,195 | I | John B Payne Living A/C |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Share Units | $0.125 | Jul 1, 2016 | M | 3,600 | D | Jul 1, 2016 | Jul 1, 2020 | Ordinary Shares | 3,600 | 0 | D |
Explanation of responses
- F1The reporting person has sole voting and dispositive power with respect to these reported securities.